Status:
COMPLETED
CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch
Lead Sponsor:
University Hospital Heidelberg
Collaborating Sponsors:
The German Heart Foundation
Klaus Tschira Stiftung, Germany
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
In December 2019, a new viral disease called COVID-19 emerged. It is caused by the new corona virus SARS-CoV-2. It was initially described in the chinese city of Wuhan. In the following months, the di...
Detailed Description
In December 2019, a new viral disease called COVID-19 emerged. It is caused by the new corona virus SARS-CoV-2. It was initially described in the chinese city of Wuhan. In the following months, the di...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of COVID-19 (detection by PCR)
- Age ≥ 18
- The patient has understood the study design and the informed consent form and has signed and dated the informed consent form
- The patient has got a cardiovascular disease or therapy with potential cardiovascular complications
Exclusion
Key Trial Info
Start Date :
April 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04376853
Start Date
April 15 2020
End Date
May 20 2022
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department III of Internal Medicine, University Hospital Heidelberg
Heidelberg, Baden-Wurttemberg, Germany, 69115